Recent research focusing on Tirzepatide at a dosage of 20mg is shedding new light on its potential applications. Initial findings suggest that this higher dosage may boost the drug's ability to control blood sugar, potentially offering more significant outcomes for individuals with type 2 diabetes. Further investigation is underway to fully explore